Synthesis 2009(20): 3460-3466  
DOI: 10.1055/s-0029-1216952
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of an Arginine Tagged [Cys155-Arg180] Fragment of NY-ESO-1: Elimination of an Undesired By-product Using ‘In House’ Resins

Paul W. R. Harris*, Margaret A. Brimble*
Department of Chemistry, University of Auckland, 23 Symonds St, Auckland 1142, New Zealand
Fax: +64(9)3737422; e-Mail: paul.harris@auckland.ac.nz; e-Mail: m.brimble@auckland.ac.nz;
Further Information

Publication History

Received 5 June 2009
Publication Date:
21 August 2009 (online)

Abstract

During the solid-phase synthesis of a peptide fragment derived from the cancer protein NY-ESO-1 incorporating a solubilising arginine tag, a significant by-product was obtained that lacked the arginine tag. The formation of this by-product (and others) was highly dependant on the quality of the resin used and was completely removed when the resin was synthesized ‘in house’.

    References

  • 1 Fields GB. Noble RL. Int. J. Pept. Protein Res.  1990,  35:  161. 
  • 2 Bouillon I. Sourai M. Miller MK. Krchnak V. J. Comb. Chem.  2009,  11:  213 
  • 3 Pugh KC. York EJ. Stewart JM. Int. J. Pept. Protein Res.  1992,  40:  208 
  • 4 Wang S.-S. J. Am. Chem. Soc.  1973,  95:  1328 
  • 5 Barlos K. Chatzi O. Gatos D. Stavropoulos G. Int. J. Pept. Protein Res.  1991,  37:  513 
  • 6 Rink H. Tetrahedron Lett.  1987,  28:  3787 
  • 7 Atherton E. Benoiton NL. Brown E. Sheppard RC. Williams BJ. J. Chem. Soc., Chem. Commun.  1981,  336 
  • 8 Atherton E. Logan CJ. Sheppard RC. J. Chem. Soc., Perkin Trans. 1  1981,  538 
  • 9a For Wang linker equivalents, see: Zinieris N. Kokinaki S. Leondiadis L. Ferderigos N. Synlett  2006,  2789 
  • 9b For 2-Cl-trityl linker equivalents, see: Zikos C. Livaniuo E. Leondiadis L. Ferderigos N. Ithakissios DS. Evangelatos GP. J. Pept. Sci.  2005,  8:  419 
  • 9c For Rink Amide linker equivalents, see: Bertnatowicz MS. Daniels SB. Koster H. Tetrahedron Lett.  1989,  30:  4645 
  • 10 Dawson PE. Muir TW. Clark-Lewis I. Kent SBH. Science  1994,  266:  776 
  • 12a Atherton E. Logan CJ. Sheppard RC. J. Chem. Soc., Perkin Trans. 1  1981,  529 
  • 12b Choma CT. Robillard GT. Englebretsen DR. Tetrahedron Lett.  1998,  39:  2417 
  • 13 Mellor SL. Wellings DA. Fehrentz J.-A. Paris M. Martinez J. Ede NJ. Bray AM. Evans DJ. Bloomberg GB. In Fmoc solid phase peptide synthesis: a practical approach   Oxford University Press; Oxford: 2000.  p.145-149  
  • 14 Rittel WR. Helv. Chim. Acta  1962,  45:  465 
  • 16 Sheppard et al. reported hydrolysis at the HMBA linker when attempting ammonolysis. This was determined to be due to moisture present in the resin, see: Brown E. Sheppard RC. Williams BJ. J. Chem. Soc., Perkin Trans. 1  1983,  75 
  • 17 King DS. Fields CG. Fields GB. Int. J. Pept. Protein Res.  1999,  36:  255 
  • 18 Reagent R. Albericio F. Kenib-Cordonier N. Bianaclanan S. Gera L. Masada RI. Hudson D. Barany G. J. Org. Chem.  1990,  55:  3730 
  • 19 Sole NA. Barany G. J. Org. Chem.  1992,  57:  5399 
  • 20 Mitchell AR. Kent SBH. Englenhard M. Merrifield RB. J. Org. Chem.  1978,  43:  2845 
  • 22a Albericio F. Barany G. Int. J. Pept. Protein Res.  1985,  26:  92 
  • 22b inventors; NeoMPS S.A. International Patent Application  W02005/095332. 
  • 24 Harris PWR. Williams GM. Shepherd P. Brimble MA. Int. J. Pept. Res. Ther.  2008,  14:  387 
  • 25 Apffel A. Fischer S. Goldberg G. Goodley PC. Kuhlmann FE. J. Chromatogr., A  1995,  712:  177 
11

Harris, P. W. R.; Brimble, M. A. manuscript in preparation.

15

Reaction of Fmoc-Arg(Pbf)-OH with TFA-TIS-H2O (95:2.5:2.5, v/v/v) gave identical HPLC and mass spectra to 6.

21

Kent, S. B. H. personal communication.

23

According to reference 2, resins that swell less than 7 mL/g in CH2Cl2 should be rejected. For commercially obtained Wang, Rink Amide AM, and 2-Cl trityl reins used here, the swelling was 6.1, 5 and 4.5 mL/g, respectively, while for the ‘in house’ reins 16 and 17, the swelling was 9 and 9.7 mL/g, respectively.